The core targets identified in this study—TP53, AKT1, VEGFA, and IL6—play critical roles in the pathogenesis of AKI, involving inflammatory responses, apoptosis, angiogenesis, and signaling pathway regulation. This evidence concerns the gene AKT1 and acute kidney injury.